Biotech · Private company · Seattle, WA, US
Pai Life Sciences, Inc.
Track this companyFree. Adds Pai Life Sciences, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- LiT4Q TLR4 Agonist Formulation for Mucosal MelanomaFiscal year 2026 · $391.3KNIH RePORTER 1R43CA298357-01A1 · fetched Nov 12, 2026
- A Vaccine for Lymphatic Filariasis, LFGuard™Fiscal year 2026 · $713.9KNIH RePORTER 5R44AI140708-07 · fetched Nov 12, 2026
- A Vaccine for Lymphatic Filariasis, LFGuard™Fiscal year 2025 · $453KNIH RePORTER 5R44AI140708-06 · fetched Nov 12, 2026
- Antigen and adjuvant selection for a vaccine against urogenital schistosomiasis, HematoshieldFiscal year 2024 · $295.4KNIH RePORTER 1R41AI181069-01 · fetched Nov 12, 2026
- A Vaccine for Lymphatic Filariasis, LFGuard™Fiscal year 2024 · $995.5KNIH RePORTER 2R44AI140708-05 · fetched Nov 12, 2026